TrialCancer immunology, immunotherapy : CII2008

Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma.

P Hersey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.